These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 28910786

  • 1. The Evolving Patterns of Uremia: Unmet Clinical Needs in Dialysis.
    Yu X.
    Contrib Nephrol; 2017; 191():1-7. PubMed ID: 28910786
    [Abstract] [Full Text] [Related]

  • 2. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
    Kirsch AH, Rosenkranz AR, Lyko R, Krieter DH.
    Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
    [Abstract] [Full Text] [Related]

  • 3. The Rationale for Expanded Hemodialysis Therapy (HDx).
    Hutchison CA, Wolley M.
    Contrib Nephrol; 2017; 191():142-152. PubMed ID: 28910797
    [Abstract] [Full Text] [Related]

  • 4. [Uremic Toxins: how can we improve the removal today?].
    Teatini U, Romei Longhena G.
    G Ital Nefrol; 2017 Sep 28; 34(5):89-101. PubMed ID: 28963830
    [Abstract] [Full Text] [Related]

  • 5. Expanded Hemodialysis: A New Therapy for a New Class of Membranes.
    Ronco C, La Manna G.
    Contrib Nephrol; 2017 Sep 28; 190():124-133. PubMed ID: 28535525
    [Abstract] [Full Text] [Related]

  • 6. Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study.
    Cornelis T, van der Sande FM, Eloot S, Cardinaels E, Bekers O, Damoiseaux J, Leunissen KM, Kooman JP.
    Am J Kidney Dis; 2014 Aug 28; 64(2):247-56. PubMed ID: 24698199
    [Abstract] [Full Text] [Related]

  • 7. The Rise of Expanded Hemodialysis.
    Ronco C.
    Blood Purif; 2017 Aug 28; 44(2):I-VIII. PubMed ID: 28486230
    [Abstract] [Full Text] [Related]

  • 8. Membrane requirements for high-flux and convective therapies.
    Bowry SK.
    Contrib Nephrol; 2011 Aug 28; 175():57-68. PubMed ID: 22188688
    [Abstract] [Full Text] [Related]

  • 9. Effects of Expanded Hemodialysis Therapy on Clinical Outcomes.
    Mitra S, Kharbanda K.
    Contrib Nephrol; 2017 Aug 28; 191():188-199. PubMed ID: 28910802
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study.
    Sevinc M, Hasbal NB, Yilmaz V, Basturk T, Ahbap E, Sakaci T, Ozcafer PN, Unsal A.
    Blood Purif; 2020 Aug 28; 49(6):733-742. PubMed ID: 32634815
    [Abstract] [Full Text] [Related]

  • 11. High-Flux Dialysis: Clinical, Biochemical, and Proteomic Comparison with Low-Flux Dialysis and On-Line Hemodiafiltration.
    Donadio C, Kanaki A, Sami N, Tognotti D.
    Blood Purif; 2017 Aug 28; 44(2):129-139. PubMed ID: 28571019
    [Abstract] [Full Text] [Related]

  • 12. The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis.
    Van Biesen W, Vanholder R, Schepers E, Glorieux G, Dhondt A, Eloot S.
    Contrib Nephrol; 2017 Aug 28; 191():168-177. PubMed ID: 28910800
    [Abstract] [Full Text] [Related]

  • 13. Membrane Innovation in Dialysis.
    Boschetti-de-Fierro A, Beck W, Hildwein H, Krause B, Storr M, Zweigart C.
    Contrib Nephrol; 2017 Aug 28; 191():100-114. PubMed ID: 28910794
    [Abstract] [Full Text] [Related]

  • 14. Clinical Performance Assessment of CorDiax Filters in Hemodialysis and Hemodiafiltration.
    Potier J, Bowry S, Canaud B.
    Contrib Nephrol; 2017 Aug 28; 189():237-245. PubMed ID: 27951574
    [Abstract] [Full Text] [Related]

  • 15. Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism.
    Zhao H, Wu D, Gyamfi MA, Wang P, Luecht C, Pfefferkorn AM, Ashraf MI, Kamhieh-Milz J, Witowski J, Dragun D, Budde K, Schindler R, Zickler D, Moll G, Catar R.
    Front Immunol; 2023 Aug 28; 14():1209464. PubMed ID: 37795100
    [Abstract] [Full Text] [Related]

  • 16. Performance of hemodialysis with novel medium cut-off dialyzers.
    Kirsch AH, Lyko R, Nilsson LG, Beck W, Amdahl M, Lechner P, Schneider A, Wanner C, Rosenkranz AR, Krieter DH.
    Nephrol Dial Transplant; 2017 Jan 01; 32(1):165-172. PubMed ID: 27587605
    [Abstract] [Full Text] [Related]

  • 17. Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients.
    Lin CL, Huang CC, Yu CC, Yang HY, Chuang FR, Yang CW.
    Am J Kidney Dis; 2003 Sep 01; 42(3):524-31. PubMed ID: 12955680
    [Abstract] [Full Text] [Related]

  • 18. Should dialysis modalities be designed to remove specific uremic toxins?
    Baurmeister U, Vienken J, Ward RA.
    Semin Dial; 2009 Sep 01; 22(4):454-7. PubMed ID: 19709001
    [Abstract] [Full Text] [Related]

  • 19. Inflammation and Protein-Energy Wasting in the Uremic Milieu.
    Jankowska M, Cobo G, Lindholm B, Stenvinkel P.
    Contrib Nephrol; 2017 Sep 01; 191():58-71. PubMed ID: 28910791
    [Abstract] [Full Text] [Related]

  • 20. High-Flux versus High-Retention-Onset Membranes: In vivo Small and Middle Molecules Kinetics in Convective Dialysis Modalities.
    Cordeiro ISF, Cordeiro L, Wagner CS, Araújo LKRP, Pereira BJ, Abensur H, Elias RM, Silva BC.
    Blood Purif; 2020 Sep 01; 49(1-2):8-15. PubMed ID: 31362299
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.